Key Points
U.S. equities have been volatile this year, but have had a strong run. The S&P 500 index gained 17.3% over the last year through Sept. 16.
However, just because the index has done well doesn’t mean you can’t find exceptions. Coca-Cola (NYSE: KO) and Eli Lilly (NYSE: LLY) have dropped more than 8% and 14%, respectively.
Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Learn More »
That might make some investors shy away from the shares. After all, the stocks have underperformed the market for various reasons.
However, long-term investors interested in dividends should view this as an excellent buying opportunity.
Image source: Getty Images.
1. Coca-Cola
Most people around the world have heard of Coca-Cola. The company, launched in 1886, sells its beverages, including its namesake brand, in more than 200 countries.
A mature company, its days of fast-growing revenue seem likely behind it. However, Coca-Cola has been increasing its top line. Second-quarter revenue, removing foreign-currency exchange fluctuations and acquisitions/divestitures, grew 5%. This helped drive adjusted operating income 15% higher.
The increased revenue was entirely due to higher prices and a changing product mix, which contributed 6 percentage points. However, lower volume subtracted 1 percentage point. That may put some investors off, but it’s likely due to consumers feeling weary from persistently high overall inflation. At some point, prices will level off and volumes will increase. Importantly, Coca-Cola’s market share in the nonalcoholic beverage sector continued to expand.
Coca-Cola shareholders have been relying on dividends, which remain an important source of the stock’s total return. In fact, they’ve come to expect regular increases, and Coca-Cola raised the payout by more than 5% in February. That ran the company’s streak to 63 straight years, making it a Dividend King.
The shares have a 3.1% dividend yield, more than double the S&P 500’s 1.2%. And Coca-Cola’s 71% payout ratio should provide comfort that the company can easily afford dividends.
2. Eli Lilly
Eli Lilly, also in existence since the late 1800s, has been very successful at developing and selling drugs used for treating diabetes, cancer, and immunology (rheumatoid arthritis), among other diseases.
It has three drugs, Mounjaro, Zepbound, and Verzenio, that account for 65% of its $15.6 billion second-quarter revenue. These drugs treat type 2 diabetes, obesity, and breast cancer, respectively. The products had top-line growth of 12% to 172%, and continue to drive revenue growth.
Second-quarter revenue grew by 38%, and adjusted earnings per share increased 61% to $6.31. Management raised its 2025 revenue guidance and now expects better than 35% revenue growth, based on the midpoint of the $60 billion to $62 billion range.
Eli Lilly continues to invest money to develop new drugs. It increased second-quarter research and development spending by 23% compared to a year ago, to $3.3 billion. It’s the biggest expense item, representing more than 21% of revenue.
It’s hard to argue with these results, but the stock may have previously gotten ahead of itself. A year ago, the shares traded at a price-to-earnings (P/E) ratio of more than 100. It now has a more reasonable 50 P/E multiple.
The stock’s 0.8% yield is below the S&P 500, but Eli Lilly’s board of directors has raised dividends annually since 2015. With a 37% payout ratio, earnings easily cover the dividend payments.
The combined appreciation potential and dividend payments give Eli Lilly’s shares an attractive total return potential.
Should you invest $1,000 in Coca-Cola right now?
Before you buy stock in Coca-Cola, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Coca-Cola wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004… if you invested $1,000 at the time of our recommendation, you’d have $661,694!* Or when Nvidia made this list on April 15, 2005… if you invested $1,000 at the time of our recommendation, you’d have $1,082,963!*
Now, it’s worth noting Stock Advisor’s total average return is 1,067% — a market-crushing outperformance compared to 189% for the S&P 500. Don’t miss out on the latest top 10 list, available when you join Stock Advisor.
*Stock Advisor returns as of September 15, 2025
Lawrence Rothman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.